Immucell (ICCC) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to -$3.9 million.
- Immucell's Enterprise Value fell 203.66% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 203.66%. This contributed to the annual value of -$3.8 million for FY2024, which is 28398.64% down from last year.
- According to the latest figures from Q3 2025, Immucell's Enterprise Value is -$3.9 million, which was down 203.66% from -$6.0 million recorded in Q2 2025.
- Over the past 5 years, Immucell's Enterprise Value peaked at -$960347.0 during Q1 2024, and registered a low of -$11.8 million during Q1 2022.
- Over the past 5 years, Immucell's median Enterprise Value value was -$4.6 million (recorded in 2025), while the average stood at -$5.7 million.
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 8683.07% in 2023, then crashed by 37892.8% in 2025.
- Over the past 5 years, Immucell's Enterprise Value (Quarter) stood at -$10.2 million in 2021, then soared by 43.14% to -$5.8 million in 2022, then soared by 83.1% to -$978741.0 in 2023, then tumbled by 283.99% to -$3.8 million in 2024, then decreased by 3.4% to -$3.9 million in 2025.
- Its Enterprise Value stands at -$3.9 million for Q3 2025, versus -$6.0 million for Q2 2025 and -$4.6 million for Q1 2025.